Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department
1 other identifier
observational
700
1 country
1
Brief Summary
Background: To evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom. Methods: Number and clinical features of patients evaluated in the pediatric ED of a single site in Milan,Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedMarch 6, 2024
March 1, 2024
1 month
March 4, 2024
March 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
During the study period, 890 evaluations were registered: the number of partecipants was 689 over the prepandemic period and 201 over the pandemic period. Mean age at evaluation was 10 years (range: 1 to 17 years).
the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).
Secondary Outcomes (1)
Evaluation rates per month were 18.1 during the prepandemic period and 8.7 during COVID-19 pandemic, with peaks in autumn and winter and drops in summer. The reduction in evaluation rate was higher for secondary headache when compared with primary one
the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).
Eligibility Criteria
patients aged 2-18 years evaluated in Pediatric Emergency Department because of headache as main symptom
You may qualify if:
- range of age: 2 - 18 years
- sex: all
- headache as main symptom
You may not qualify if:
- headache in the context of head trauma, because of different diagnostic-care in Pediatric Emergency Department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric Emergency Department Clinica de Marchi, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 6, 2024
Study Start
April 30, 2022
Primary Completion
May 30, 2022
Study Completion
May 30, 2022
Last Updated
March 6, 2024
Record last verified: 2024-03